Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage

Clinical trial NCT07218185 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07218185
Sponsor: Cerus Corporation
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Hypofibrinogenemia Hemorrhage Trauma Associated Hemorrhage Hemorrhagic Shock

Start date: 2026-07-01
Primary completion: 2028-07-01
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.